Portfolio now spans seven patent families and 19 pending applications across seven jurisdictions, pr

Portfolio now spans seven patent families and 19 pending applications across seven jurisdictions, pr

Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular

 Building on the result, Decoy has opened an exploratory program to design D-MAVs against filoviruse

Lead D-MAV demonstrates cross-viral family fusion inhibition, validating theplatform; opens a new pr

Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session

CAMBRIDGE, Mass., July 15, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnol

Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark

Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#

Gainers Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market s

AeroVironment, Inc. (NASDAQ: AVAV) jumped 21.4% in pre-market trading after reporting strong financi

Gainers Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 poi

Decoy Therapeutics Inc. (NASDAQ:DCOY) shares are trading higher. The company announced a $21 million

Decoy Therapeutics shares are surging Monday after a $21 million private placement financing with a

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday&

CMCSA: 25% | Comcast To Separate Into Two Independent Publicly Traded Companies Through Tax-Free Spi

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announ

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing PR Newswire HOUSTON

HOUSTON, June 26, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the "Company" or "De

Rick Pierce to join speakers from Boehringer Ingelheim, RA Capital and ILiAD Biotechnologies for dis

CAMBRIDGE, Mass., June 3, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnolo

hVIVO PLC's (AIM:HVO) consultancy contract with Decoy Therapeutics, announced on Monday, is a small

hVIVO PLC (AIM:HVO), the clinical development company specialising in human challenge trials, has si

Collaboration supports Phase 1 and Phase 2a human proof-of-concept studies for new antiviral categor

Appointment deepens scientific leadership as Decoy advances its Designable Multi-Antiviral pipeline

Decoy Therapeutics (NASDAQ:DCOY) reported quarterly losses of $(4.18) per share which missed the ana

CBO Peter Marschel to Lead HubXchange Roundtable on Computational Peptide Design CSO Dr. Barbara Hib

Decoy Therapeutics Inc. (DCOY) Discusses Corporate Overview and Pipeline Progress in Antiviral Drug

Highly differentiated AI-powered D-MAV discovery platform targeting drugdiscovery in the multi-billi

Live video webcast with Rick Pierce, Chief Executive Officer of Decoy Therapeutics, on Thursday, Apr

Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), announces that on March 31, 2026 th

CAMBRIDGE, Mass. and HOUSTON, April 2, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY)

ProMetic Life Sciences (OTCMKTS:PFSCF - Get Free Report) and Decoy Therapeutics (NASDAQ: DCOY - Get

Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a biotechnology company pioneering

Partnership supported by funding from Google Cloud will increase Decoy's computational peptide desig

Decoy Therapeutics Inc. (NASDAQ:DCOY), a preclinical-stage biopharmaceutical company that is enginee

CAMBRIDGE, Mass., March 5, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (NASDAQ: DCOY), a preclinica

Ladenburg Thalmann analyst Kevin DeGeeter initiates coverage on Decoy Therapeutics (NASDAQ:DCOY)

Decoy Therapeutics will use the platform, with funding support from the Gates Foundation, to provide